
Gelesis Holdings, Inc.
Gelesis Holdings, Inc. (GLS) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · GLS · as of Jun 30, 2023
Ownership Breakdown
1
Institutional Holders
▼ 1 vs Q1
$1
Total Inst. Value
▼ $11,258 vs Q1
73.33M
Shares Outstanding
freeFloat 33.82%
52
13F Shares Held
▼ 69,153 vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
GLS largest shareholders · institutional ownership
Q2 2023 · SEC 13F
Showing top 2 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BARCLAYS PLC pharmaceutical preparations | 52 | 0.01% | 0.01% | $2,000 | Mar 27, 2026 | ▼ 9.9K |
NEW YORK STATE COMMON RETIREMENT FUND pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Oct 8, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2023 vs prior quarter
Q2 2023
0
Increased
+0 shares0
New Positions
first time holders1
Decreased
−9.9K shares1
Sold Out
fully exitedNet shares change (top 50)
9.9K
+0 / −9.9K
Net new holders
-2
0 new / 1 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
GLS insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
PureTech Health plc 10 percent owner | Sep 20, 2023 | Purchase | 0 | $0.05 | $0 | 0 | Form 4 ↗ |
PureTech Health plc 10 percent owner | Jun 12, 2023 | Purchase | 0 | $0.01 | $0 | 0 | Form 4 ↗ |
PureTech Health plc 10 percent owner | May 26, 2023 | Purchase | 43,133,803 | $0.01 | $612.5K | 43.13M | Form 4 ↗ |
PureTech Health plc 10 percent owner | May 26, 2023 | Purchase | 0 | $0.01 | $0 | 0 | Form 4 ↗ |
PureTech Health plc 10 percent owner | May 1, 2023 | Purchase | 192,307,692 | $0.02 | $3.50M | 192.31M | Form 4 ↗ |
PureTech Health plc 10 percent owner | May 1, 2023 | Purchase | 23,688,047 | $0.27 | $6.50M | 23.69M | Form 4 ↗ |
PureTech Health plc 10 percent owner | May 1, 2023 | Purchase | 5,000,000 | $0.27 | $1.37M | 5.00M | Form 4 ↗ |
PureTech Health plc 10 percent owner | May 1, 2023 | Purchase | 2,000,000 | $0.02 | $36.4K | 2.00M | Form 4 ↗ |
KUCHERLAPATI RAJU S director | Nov 21, 2022 | Purchase | 92,000 | $0.45 | $41.4K | 190.3K | Form 4 ↗ |
KUCHERLAPATI RAJU S director | Nov 18, 2022 | Purchase | 8,000 | $0.39 | $3.1K | 98.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Gelesis Holdings, Inc. (GLS) is primarily owned by institutional investors, who hold approximately 0.0% of total shares outstanding. Company insiders own approximately 66.18%, while retail and public investors account for the remaining 33.82%.
The largest institutional shareholder of Gelesis Holdings, Inc. is BARCLAYS PLC, holding approximately 52 shares — equal to 0.01% of outstanding shares — as of June 30, 2023.
A total of 1 institutional investors currently hold GLS stock, with a combined institutional value of approximately $1 as of the most recent 13F filing period.
Frequently asked questions
GLS ownershipGelesis Holdings, Inc. (GLS) is primarily owned by institutional investors, who hold approximately 0.0% of shares. The largest shareholder is BARCLAYS PLC with a 0.01% stake. Company insiders hold 66.18%. Data sourced from SEC Form 13F as of June 30, 2023.